E

ELEVAI Labs Inc
NASDAQ:ELAB

Watchlist Manager
ELEVAI Labs Inc
NASDAQ:ELAB
Watchlist
Price: 2.13 USD -2.29% Market Closed
Market Cap: 2.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ELAB stock under the Base Case scenario is 1.92 USD. Compared to the current market price of 2.13 USD, ELEVAI Labs Inc is Overvalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ELAB Relative Value
Base Case
1.92 USD
Overvaluation 10%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
85
vs Industry
44
Median 3Y
65.2
Median 5Y
65.2
Industry
1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-29.1
Median 5Y
-29.1
Industry
16.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-27.1
Median 5Y
-27.1
Industry
11.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-25.2
Industry
16.6
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
80
vs Industry
84
Median 3Y
6.5
Median 5Y
6.5
Industry
1.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
14
Median 3Y
62.5
Median 5Y
62.5
Industry
1.1
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
32
Median 3Y
87.9
Median 5Y
87.9
Industry
3.8
More Details
0.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.8
vs History
4
vs Industry
69
Median 3Y
-27.7
Median 5Y
-27.7
Industry
9.9
More Details
0.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.8
vs History
4
vs Industry
66
Median 3Y
-27.6
Median 5Y
-27.6
Industry
12.7
More Details
0.7
EV/OCF
EV/OCF
Enterprise Value to OCF
0.7
vs History
4
vs Industry
68
Median 3Y
-26
Median 5Y
-26
Industry
12.2
More Details
0.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.7
vs History
4
vs Industry
57
Median 3Y
-25.3
Median 5Y
-25.3
Industry
14.8
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
18
Median 3Y
41.3
Median 5Y
41.3
Industry
1.2
More Details

Multiples Across Competitors

ELAB Competitors Multiples
ELEVAI Labs Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ELEVAI Labs Inc
NASDAQ:ELAB
2.9m USD 1.7 -0.5 0.8 0.8
US
Kenvue Inc
NYSE:KVUE
40.6B USD 2.7 38.5 14.7 18.1
BR
Natura &Co Holding SA
OTC:NTCOY
7.7B USD 1.4 -4.7 20.6 34.8
CN
Mao Geping Cosmetics Co Ltd
HKEX:1318
51.5B HKD 12.1 53.5 35.6 38
KR
APR Co Ltd
KRX:278470
5.6T KRW 6.7 42.3 32.2 37.6
IL
Oddity Tech Ltd
NASDAQ:ODD
3.9B USD 5.6 37.1 29 31.5
KY
Herbalife Ltd
XMUN:HOO
2.3B EUR 0.6 9.7 6.3 7.6
CN
Runben Biotechnology Co Ltd
SSE:603193
13.3B CNY 10.1 44.3 38.3 38.3
KR
d'Alba Global Co Ltd
KRX:483650
2.3T KRW 0 0 0 0
CN
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
8.3B CNY 7.4 67.1 58.3 58.3
IN
Honasa Consumer Ltd
NSE:HONASA
99.3B INR 4.9 138.3 136.5 397.6
P/E Multiple
Earnings Growth PEG
US
E
ELEVAI Labs Inc
NASDAQ:ELAB
Average P/E: 53.8
Negative Multiple: -0.5 		N/A N/A
US
Kenvue Inc
NYSE:KVUE
38.5
35%
1.1
BR
Natura &Co Holding SA
OTC:NTCOY
Negative Multiple: -4.7 N/A N/A
CN
M
Mao Geping Cosmetics Co Ltd
HKEX:1318
53.5
29%
1.8
KR
A
APR Co Ltd
KRX:278470
42.3
26%
1.6
IL
O
Oddity Tech Ltd
NASDAQ:ODD
37.1
20%
1.9
KY
H
Herbalife Ltd
XMUN:HOO
9.7
12%
0.8
CN
Runben Biotechnology Co Ltd
SSE:603193
44.3
N/A N/A
KR
d
d'Alba Global Co Ltd
KRX:483650
Not Available N/A N/A
CN
D
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
67.1
20%
3.4
IN
H
Honasa Consumer Ltd
NSE:HONASA
138.3
53%
2.6

See Also

Summary
ELAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELAB stock valuation using valuation multiples.
Wall Street Estimates
ELAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 263,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.